ClinicalTrials.Veeva

Menu

Immunological Tolerance After Frequent Rabies Booster Vaccinations

Q

Queen Saovabha Memorial Institute

Status

Unknown

Conditions

Rabies

Treatments

Biological: Blood drawn after rabies vaccine booster vaccination

Study type

Interventional

Funder types

Other

Identifiers

NCT03729102
QSMI-IRB 2/2018

Details and patient eligibility

About

To study immunological tolerance effect after frequent rabies booster vaccination

Full description

Previous studies had shown lower antibody titers among those who received frequent rabies booster vaccination, compared to ones who had got primary immunization. We study immunological cells i.e., regulatory T cell, regulatory B cell, T follicular helper cell, and cytokines in those who received frequent rabies booster vaccination.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy adults
  • Previously received rabies vaccination

Exclusion criteria

  • Had immunocompromised conditions
  • Received blood or blood product within 3 months
  • Received anti-malarial drugs

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Control group
Active Comparator group
Description:
Persons who had received primary immunization
Treatment:
Biological: Blood drawn after rabies vaccine booster vaccination
Study group
Experimental group
Description:
Persons who had received primary immunization and later received booster vaccination for at least 3 times
Treatment:
Biological: Blood drawn after rabies vaccine booster vaccination

Trial contacts and locations

1

Loading...

Central trial contact

Terapong Tantawichien, MD; Suda Sibunruang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems